Atovaquone

FDA Approved: * March 18, 2014
Pharm Company: * AMNEAL PHARMS
Category: Malaria

Atovaquone, sold under the brand name Mepron, is a quinone antimicrobial medication for the prevention and treatment of Pneumocystis jirovecii pneumonia (PCP).[2] Atovaquone is a chemical compound that belongs to the class of naphthoquinones. Atovaquone is a hydroxy-1,4-naphthoquinone, an analog of both ubiquinone and lawsone, with antipneumocystic activity. Contents 1 Medical uses 2 Malaria 3 Research 3.1 COVID-19 4 Veterinary use 5 References 6 Further reading 7 Externa... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Atovaquone 750 mg/5ml Oral Suspension
NDC: 0121-0888
Labeler:
Pharmaceutical Associates, Inc.
Atovaquone 750 mg/5ml Oral Suspension
NDC: 0121-0898
Labeler:
Pharmaceutical Associates, Inc.
Atovaquone 750 mg/5ml Oral Suspension
NDC: 0121-1016
Labeler:
Pai Holdings, LLC
Atovaquone 1500 mg/10ml Oral Suspension
NDC: 0121-1796
Labeler:
Pharmaceutical Associates, Inc.
Atovaquone 750 mg/5ml Oral Suspension
NDC: 0904-7064
Labeler:
Major Pharmaceuticals
Atovaquone 750 mg/5ml Oral Suspension
NDC: 0904-7459
Labeler:
Major Pharmaceuticals
Atovaquone Oral Suspension Oral Suspension 750 mg/5ml Oral Suspension
NDC: 10702-223
Labeler:
Kvk-tech, Inc.
Atovaquone 750 mg/5ml Oral Suspension
NDC: 16714-900
Labeler:
Northstar Rx LLC
Atovaquone 750 mg/5ml Oral Suspension
NDC: 17856-0631
Labeler:
Atlantic Biologicals Corp.
Atovaquone 750 mg/5ml Oral Suspension
NDC: 31722-629
Labeler:
Camber Pharmaceuticals, Inc.
More Results

Related Brands

Drugs with the same active ingredients